| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
59,154 |
50,137 |
$3.21M |
| 99215 |
Prolong outpt/office vis |
11,746 |
9,701 |
$921K |
| J2323 |
Injection, natalizumab, 1 mg |
355 |
206 |
$825K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,350 |
16,581 |
$691K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
6,664 |
5,763 |
$605K |
| 99205 |
Prolong outpt/office vis |
5,690 |
4,964 |
$598K |
| 95886 |
|
10,444 |
6,644 |
$553K |
| 95816 |
|
4,874 |
4,258 |
$488K |
| 99233 |
Prolong inpt eval add15 m |
8,218 |
3,967 |
$374K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,152 |
617 |
$319K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
8,383 |
3,569 |
$243K |
| 99223 |
Prolong inpt eval add15 m |
3,225 |
2,806 |
$237K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
2,901 |
2,582 |
$192K |
| 95819 |
|
1,073 |
907 |
$97K |
| 95720 |
|
889 |
434 |
$96K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,022 |
613 |
$47K |
| 95811 |
|
613 |
565 |
$30K |
| 64615 |
|
869 |
709 |
$28K |
| 99222 |
Initial hospital care, per day, moderate complexity |
368 |
325 |
$24K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
400 |
357 |
$23K |
| 95913 |
|
121 |
105 |
$23K |
| 95951 |
|
676 |
247 |
$20K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
940 |
425 |
$15K |
| 95806 |
|
449 |
367 |
$14K |
| 95718 |
|
131 |
117 |
$8K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
43 |
37 |
$8K |
| 99152 |
|
820 |
654 |
$6K |
| 95782 |
|
43 |
39 |
$4K |
| 95908 |
|
255 |
225 |
$3K |
| 95909 |
|
378 |
340 |
$3K |
| 95910 |
|
168 |
153 |
$3K |
| 92540 |
|
29 |
25 |
$2K |
| 62323 |
|
26 |
26 |
$2K |
| 95885 |
|
66 |
49 |
$1K |
| 99221 |
|
35 |
34 |
$1K |
| 99220 |
|
190 |
152 |
$540.73 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
25 |
15 |
$386.21 |
| 96415 |
|
16 |
13 |
$273.89 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
24 |
19 |
$273.66 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
45 |
38 |
$136.73 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
15 |
12 |
$136.43 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
17 |
13 |
$49.53 |
| 95911 |
|
155 |
135 |
$0.00 |
| 99217 |
|
96 |
74 |
$0.00 |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
12 |
12 |
$0.00 |